The fusogenic function of HIV-1 gp41 transmembrane Env subunit relies on two different kinds of structural elements: i) a collapsible ectodomain structure (the hairpin or six-helix bundle) that opens and closes, and ii) two membrane-transferring regions (MTRs), the fusion peptide (FP) and the membrane-proximal external region (MPER), which ensure coupling of hairpin closure to apposition and fusion of cell and viral membranes. The isolation of naturally produced short peptides and neutralizing IgG-s, that interact with FP and MPER, respectively, and block viral infection, suggests that these conserved regions might represent useful targets for clinical intervention.
I. Introduction: membrane-transferring regions within the globular gp41 ectodomain.
Membrane fusion comprises a multi-step, highly regulated physiological reaction that proceeds mechanically coupled to the basic processes of local rupture (exposure of the hydrophobic interior) and deformation (bending) of lipid bilayers (reviewed in [1] [2] [3] [4] ).
The human immunodeficiency virus type-1 (HIV-1) relies on the fusogenic activity of the envelope glycoprotein (Env) to enter and infect its CD4 + host cells [5] [6] [7] . The HIV-1 fusion machinery shares a number of common features with other fusogenic viral glycoproteins [8] [9] [10] [11] : functional priming at the cell surface through proteolytic processing of Env gp160 precursor to render non-covalently bound surface (gp120) and transmembrane (gp41) subunits; an oligomeric organization (homotrimers of gp120-gp41 heterodimers); fusogenic activity localized into ecto-and transmembrane domains of the integral gp41 subunit; and the presence of a fusion peptide (FP), a highly conserved, hydrophobic domain, which, in the case of HIV-1, is located at the free amino terminus of the fusogenic gp41 subunit.
From a structural point of view, HIV-1 Env belongs to the "Class I" fusion proteins, characterized by their transmembrane subunit's capacity to fold into a highly stable 6-helix bundle (6-HB) [6, 10, 11] . In this "hairpin-like" trimeric structure three helices pack in the reverse direction against hydrophobic grooves outside a triple-stranded coiled-coil, so that the ectodomain amino-and carboxy-termini are placed at the same end of the molecule (Figure 1 ). It is generally assumed that amino-terminal FP sequences insert into the target cell membrane in the "pre-hairpin" stage created upon receptor/co-receptor binding [12] [13] [14] . Subsequent production of the 6-HB structure would therefore induce close apposition of the viral and cell membranes anchored through the transmembrane domain (TMD) and the FP, respectively. According to this view, the N-terminal FP would function as an inert anchor, i.e., a "secondary" TMD that, together with the "primary" TMD, would transmit the force generated by 6-HB formation into the target membrane.
However, two main observations point to an active role of gp41 ectodomain sequences at modulating the bilayer elastic stress during membrane fusion. In one hand, mutant fusion domains have been isolated that are capable of integrating into target bilayers, and yet they do not support fusion activity [15, 16] indicating that simple insertion as an inert membrane anchor is not enough to unleash FP function. On the other hand, in the context of the 6-HB, the C-terminal helices are not directly followed by TMDs ( Figure   1A ). In HIV-1 an intervening sequence of approximately 20 amino acids, termed as the membrane proximal external region (MPER), separates both gp41 domains [17, 18] . In fact, a soluble and structurally irregular MPER linker might keep the 6-HB far from the close contacting dehydrated areas required for membrane fusion initiation (as far as 70 Å apart from the viral membrane). It was thus argued that the transmission of the force generated upon folding into the 6-HB required the establishment of direct contacts between the MPER and the HIV membrane [19] .
Wimley-White (WW) hydrophobicity scales can provide valuable tools for the detection of membrane-active domains, particularly useful in the case of viral products that insert into membranes of the host cells (reviewed in [20, 21] ). These scales are based on partitioning free energies of individual amino acids (including the peptide bond) from water into membrane interfaces (!G wiu ) or octanol (!G wio ) [22] . When applied to HIV-1 gp41 ectodomain the hydrophobicity-at-interface WW scale displays a positive peak that is indeed coincident with the N-terminal FP sequence ( Figure 1A ). In addition, a positive maximum spanning MPER is detected at the C-terminus, thereby indicating that both hairpin ends are endowed with the capacity for transferring from water into the membrane interface (MI). The gp41 ectodomain membrane-transferring regions (MTRs) can be operationally defined based on two distinct characteristics: i) their favorable free energy of partitioning from water into the MI; and ii) their intrinsic capacity for perturbing the lipid bilayer architecture upon insertion (membrane activity). MTR partitioning into membranes has been quantitatively assessed in vesicular model systems using representative synthetic peptides [12, [29] [30] [31] [32] [33] [34] [35] [36] [37] . These studies not only confirm the predicted high affinity of MTRs for the membrane interface, but also support their role as promoters of lipid bilayer destabilization [12, 13, 34, [36] [37] [38] . In principle MTR-s might promote fusion by reducing the formation energies of the lipidic intermediates of fusion, and/or by accelerating the opening of fusion pores [39] [40] [41] .
Given their common membrane topology at equilibrium, i.e., inserted at the level of the interface-hydrocarbon region of one monolayer, it has been proposed that MTRs may induce lateral stress in the hydrocarbon region of the external monolayer and/or selectively induce an increment of its surface [34, [42] [43] [44] [45] . These effects would result in the creation of bulges (or dimples) that protrude from the membrane plane [46] . The tops of these structures are highly curved, an arrangement that can facilitate the formation of lipidic contacts between fusing bilayers [46] . Alternatively, based on the evidence that MTRs may lower the membrane rupture tension [47] , it has been proposed that a plausible mechanism of MTR-mediated fusion-promotion could be the destabilization of bilayer diaphragms at hemifusion intermediates [40] . Yet another line of evidence derived from diffuse x-ray scattering experiments, indicates that the FP inserted in membranes might reduce the bending energy, and, hence, facilitate the formation of curved lipidic intermediates of fusion [41] .
II: HIV-1 fusion inhibition by targeting the fusion peptide
The most widely accepted mechanism of HIV-1 Env-mediated fusion introduced in the previous section encompasses two key processes ( Figure 1B ): 1) Insertion of MTRs into the fusing membranes, and 2) Collapse of the pre-hairpin intermediate into an
energetically stable 6-HB structure. Since entry inhibition may block early stages of viral infection, the large conformational changes that are the energy source for membrane fusion constitute an important target in development of antiviral therapies.
The HIV fusion inhibitors derived from the C-terminal heptad repeat region (CHR) comprise a family of peptide-based compounds, some of them, such as the T-20 derivatives, currently in clinical use [48] . These molecules dominantly compete with gp41 helical sequences for binding to hydrophobic grooves transiently exposed at the ectodomain surface [5, 6] . Thus, it is postulated that T-20-like peptides block close contact between cell target and viral membranes by preventing 6-HB formation.
Although highly effective, the clinical use of these compounds is circumscribed to rescue therapies against multidrug resistant viruses [48] . Bioavailability issues, including rapid proteolytic degradation, and consequent requirement of high doses delivered by injection, pose a serious limitation to their wider application.
In theory the gp41 MTRs that transfer into and perturb membranes may comprise alternative/complementary targets for antiviral development. MTR membrane-activity is dependent on the adoption of structurally defined oligomeric complexes at membrane surfaces, a requirement that might explain, at least in part, their high degree of sequence conservation [19, [30] [31] [32] . Mutagenesis studies have put forward the absolute requirement of the FP sequence for gp41 fusogenic activity [49] [50] [51] . Amino acid homology between fusion proteins of different viruses is usually of less than 20%. In contrast FP homology for the same proteins can be as high as 90% [52] . FPs are also unusually enriched in Ala and Gly residues [53] . Comparable high degrees of residue conservation and Ala/Gly content are not found in other membrane-associated hydrophobic protein domains as signal sequences or transmembrane anchors, suggesting that FP sequences have evolved constrained by a selective pressure that cannot be explained by simple requirements of hydrophobicity or amphipathicity.
Supporting the existence of a tight structure-function relationship, Longo et al. [54] identified a pore-formation activity of the functional FP well below the membrane rupture tensions caused by simple transfer of mass to the bilayers. Thus, the ability to perturb the bilayer architecture after insertion seems to be an intrinsic feature of functional viral FPs, which probably requires formation of specific membraneembedded complexes [42] .
Interference with formation of these structurally defined oligomeric complexes might also explain the inhibitory effect displayed by short peptides derived from the FP sequence in cell systems. A hexapeptide which was identical in amino acid sequence to the gp41 N-terminus was found by Owens and coworkers [55] to completely inhibit syncitium formation mediated by HIV-1 envelope glycoproteins expressed at the surface of HeLa CD4+ cells. The inhibitory effect was sequence-specific and dosedependent. Longer HIV-1 FPs inhibited HIV-induced syncytium formation and antigen production in infected cells [56] . When peptide solubility was increased by a Cterminus conjugation to charged polymers an increase in inhibitory activity was found; 2) Coupled to partitioning, the FP attains a helical structure at the membraneinterface.
3) Following the structuring step, a surface aggregation of helical peptides occurs.
4) When the structure and conformation of the peptides are appropriate, the aggregates that have reached a critical size will form a permeating pore.
In this model, the kinetics of leakage (panel C) is dictated by the kinetics of surface aggregation, bilayer translocation and aqueous pore opening, since once a pore has formed the leakage of all the contents occurs within less than 1s, thus yielding a finite final extent. In accordance with this model, FP blocking agents may potentially act by interfering with partitioning (i.e., generating a water soluble complex with reduced !G wiu ), hindering the conformational changes and/or oligomerization processes taking place at the bilayer surface, or occluding the aqueous channel.
FP-dependent pore formation in POPG vesicles was therefore used as the functional assay to screen the PS-SCL for the identification of compounds that inhibited FP activity [73] . The peptide mixtures that defined the library, were pre-mixed with FP in DMSO prior to addition to the POPG large unilamellar vesicle (LUV) suspension. As shown in Figure 2E , the 82-2 and 82-5 compounds inhibited fusion in a dosedependent manner showing apparent 50% inhibitory concentration (IC 50 ) values of ca.
20 µM and 100 µM, respectively. The observation that a sequence bearing D-proline in position 2 (Ac-gpidqv-NH2) was not inhibitory of FP membrane activity or gp41-induced cell-cell fusion emphasizes the specificity of the process. The inhibitory potency of these compounds was ca. x500-1000 times lower (when weight was considered) than that exhibited by the T-20 peptide in the same assay [73] , but nonetheless comparable to that reported for the first generation of PIEs in similar cellcell fusion inhibition assays [62] . Research work is under progress in our laboratories in order to precisely elucidate the stage between bilayer partitioning and pore-opening that is targeted by D-hexapeptides. Our expectation is that characterizing the inhibition mechanism of pore-formation in the vesicular systems will provide valuable starting information to attempt the resolution of the mechanism underlying gp41-induced fusion inhibition. We also surmise that isolating the FP stage relevant for inhibition may guide future structural studies. Recent structure-assisted redesign of PIE sequences has yielded optimized versions displaying IC 50 values in the order of pM in neutralization assays [63] . Thus, the first generation of anti-FP D-hexapeptides might also comprise leading platforms for inhibitor optimization in the near future.
IV. MPER structure-function
The MPER sequence encompasses the second class of gp41 MTR. Based on mean interfacial hydrophobicity calculations we proposed this sequence to span MPER mutant devoid of interfacial hydrophobicity by substituting alanine residues for the five tryptophan residues within this sequence [17, 21] . Subsequent functional studies revealed that membrane fusion induced by gp41 devoid of MPER interfacial hydrophobicity was arrested at the stage of non-expanding small fusion pores [75] , which suggests a role during post-lipid mixing stages [76] .
The membrane-activity of MPER-derived peptides detected in vitro provides experimental evidence to support a functional role for this gp41 MTR during fusion [18, 25, 77] . Characterization of the HIV-1 lipidome has revealed high levels of cholesterol (Chol) and sphingomyelin (SPM) [78] [79] [80] , an observation that correlates with the selectivity for specific segregated membrane regions through which virions emerge during maturation [81, 82] . The membrane activity of the MPER-derived peptide 664 DKWASLWNWFNITNWLWYIK 683 (PreTM) was modulated by these envelope lipids [77] . Specifically, Chol greatly stimulated PreTM's lytic activity and activated its fusogenic capacity [77] . When PC, SPM and Chol were combined to emulate conditions of liquid ordered (Lo)-liquid disordered (Ld) lipid domain segregation, putatively existing at the external membrane monolayer of HI virion, high levels of PreTM surface self-aggregation, concomitant to an enhancement in fusion and lytic activities were observed at low peptide doses (in the order of 1:1000 peptide-to-lipid ratio). Conditions described to disturb occurrence of lateral separation of Lo-Ld lipid phases in these systems, reproduced the high peptide-dose requirements for leakage as found in pure PC vesicles and inhibited fusion [77] . Thus, the lipid dependence observed in the vesicular systems suggests a functional role for MPER membrane activity in destabilizing the envelope lipid bilayer architecture at the loci of fusion.
The possible existence of a direct interaction between Chol and PreTM domain was already posited by Salzwedel et al. [17] . MPER carboxy-terminal LWYIK sequence has been identified as a potential "cholesterol recognition/interaction amino acid consensus" Some of the produced gp41 chimeras indeed retained fusion activity [90] , therefore demonstrating that MPER can be replaced by a membrane-disruptive foreign sequence and preserve its biological function.
Structural studies support that membrane-active MPER may fold within the lowpolarity membrane-interface environment adopting a helical conformation, and also self-aggregate therein (Figure 3 ). NMR spectroscopy studies by Schibli et al. [43] revealed the formation of a well-defined helical structure for 665 KWASLWNWFNITNWLWYIK 683 peptide monomers in dodecylphosphocholine (DPC) micelles ( Figure 3A, left panel) . Four of the five tryptophan residues, as well as the tyrosine residue, formed a "collar" of aromatic residues along the axial length of the helix. Nuclear Overhauser effects to the headgroup and interfacial protons of protonated dodecylphosphocholine confirmed that the aromatic residues are positioned within the membrane-water interface of a phospholipid bilayer sustaining a "Velcro-like"
interaction. The bulk of the polar residues are positioned on one face of this structure, with the hydrophobic phenylalanine side chain on the opposing face, forming an amphipathic structure.
Subsequent analyses of the MPER sequence including the application of the hydrophobic-at-interface moment to the numerous mutations generated by Salzwedel and coworkers [17] revealed that this gp41 MTR might be segmented into two A more recent DPC-NMR structure reported by Sun et al. [93] provided the structural basis for the functional segmentation of this gp41 MTR (see also Figure 3A , right panel). The MPER sequence 662 ELDKWASLWNWFNITNWLWYIK 683 analyzed by these authors was elongated at the N-terminus by including the E662 and D664 polar residues. The conformationally defined elements present in the structure included a tilted "-helix (664-672), a short hinge connection (673-674), and a flat helix running in parallel to the membrane plane (675-683). The N-terminal segment contained a two-turn "-helix, whereas a one-turn "-helix was combined with a short 3 10 -helix within the Cterminal segment. This kinked structure optimizes the hydrophobic surface for membrane insertion with 4 out of the 5 Trp residues plus F673 facing the MI/hydrocarbon core (HC) interface. Moreover, side-chains of most polar residues remain solvent exposed. Remarkably, as pointed out by these authors, the membraneburied residues are the most conserved, whereas the hydrophilic-exposed residues seem to be subject of greater variability.
Low-resolution structural techniques provide additional evidence for the existence of 
V. MPER as a target for fusion inhibition.
The ability displayed by MPER-derived PreTM peptide to self-associate in membranes raised the possibility that formation of structurally defined MPER homo-oligomers might take place at some stage during gp41-induced fusion process [19] . It was assumed that this process might represent an alternative target for potential inhibitors.
Competition with MPER self-oligomerization, and hence, fusion inhibition was tested potently inhibited viral infectivity in tissue culture (IC 50 " 4 nM) [97] [98] [99] . Antiviral activity of the leading MPER-derived sequence was found to map to a short segment containing three conserved Trp residues. Thus, further analyses focused on a derivative of eight amino acids ( 770 WEDWVRWI 777 ), designated C8, which still displayed potent antiviral activity (IC 50 " 40 nM). C8 activity was found to be dependent on conservation of the Trp motif, most likely because these residues are responsible for its conformational propensity. Furthermore, the retroinverso analogue of this peptide (riC8)
has been shown to be effective in vivo, in experiments demonstrating its ability to decrease mean viral load when administered to chronically FIV-infected cats [99] .
As mentioned in the previous section, perturbation of the integrity of lipid bilayers by peptide doses relevant for spike density in the viral membrane [100] and the Chol effect on this phenomenon [101, 102] [108] [109] [110] . Thus, the full 2F5 epitope roughly corresponds to the MPER AIS, while the 4E10 epitope starts at the junction between the hydrophobic subdomains and ends close to the MPER C-terminus.
These crystal structures also reveal long third complementarity-determining region of the heavy chains (CDR H3s) containing solvent-exposed aromatic residues.
Accordingly, it has been suggested that 2F5 and 4E10 antibodies share a common adaptive trait for epitope recognition at the membrane surface [108, 111, 112] . Recent mutagenesis studies actually indicate that neutralizing activity might be dependent on antibody-membrane association, which would require the preservation of hydrophobicat-interface CDR H3 loop residues [113] [114] [115] [116] . Thus, determining the optimal conditions for membrane-inserted epitope recognition and subsequent membrane activity blocking may provide useful information for the rational design of effective liposome-peptide immunogens.
In principle, antibody recognition-blocking may be conditioned by the structure and dynamics of the membrane-embedded MPER sequence, which are in turn predicted to depend on the length and composition of the MPER-derived peptide sequence considered (i.e., the inclusion of the different hydrophobic subdomains [117] ), and the lipid composition of the model membrane (i.e., the presence of envelope lipids Chol and/or SPM [105, 106] ). Figure 3 compiles results on mAb4E10-MPER peptide interactions reported in previous works [92, 105, 106] , which exemplify the effect of peptide structure on mAb recognition and membrane-activity blocking. The PreTM peptide is structurally represented by the interfacial helix described by Schibli et al.
[43](PDB entry: 1JAV). Within this continuous structure, residues W672 and F673 face towards the HC region of the membrane. A comparable orientation of these residues was observed within the bipartite structure reported by Sun et al. [93] (PDB entry: 2PV6). This structure might be representative of longer MPER specimens, such as AISpreTM, bearing higher polarity at the N-terminus. Both structures also expose N671
to the solvent. In contrast, the W680 residue remains buried into the MI-HC interface within the shorter, continuous helical 1JAV structure, while the chain reorientation introduced by the connecting hinge induces its exposure to solvent within the longer 2PV6 structure.
Lorizate et al. [105] reported surface pressure measurements compatible with the partial extraction by 4E10 of PreTM peptide from lipid monolayers (see also Figure 4 ) and Sun et al. [93] provided electron-paramagnetic resonance data compatible with 4E10 epitope extraction from the longer 662-683 MPER peptide inserted into lipid bilayers. These authors observed that extracted W672 and F673 side chains rearrange within the 4E10 paratope, and that, particularly the latter residue, flips vertically and inserts deeply into the epitope-binding pocket. Sun et al. [93] also hypothesized that solvent exposed N671
and W680 were key residues in 4E10 recognition of membrane-inserted MPER by guiding the initial contacts with CDR3 regions of the antibody. Thus, given the fact that only the former would be accessible in a membrane-bound state, mAb4E10 is predicted to recognize-block the shorter MPER-derived PreTM peptide with lower affinity.
The Figures 3C and D display respectively peptide-induced leakage inhibition and antibody-vesicle association results, which, in conjunction, provide evidence for higher antibody affinity towards the membrane-bound peptide exposing W680 to solvent. 4E10
blocked the leakage process induced by the long AISpreTM peptide with an IC 50 of ca.
10 nM, while an order of magnitude higher IC 50 value of ca. 100 nM was measured for the inhibition of leakage induced by the shorter PreTM peptide ( Figure 3C ). The actual levels of mAb-liposome association, as detected by flow-cytometry, also reflected the higher affinity of 4E10 towards vesicles containing the longer MPER peptide ( Figure   3D ). The implication of W680 in 4E10 recognition at the membrane surface therefore supports that this invariant residue should be exposed to the immune system in membrane-model formulations aimed at eliciting 4E10-like neutralizing antibodies.
Previously published results also support the capacity of lipids for modulating the membrane-inserted epitope recognition process. Explicitly, blocking by 4E10 antibody of membrane-restructuring induced by MPER-derived peptides has been shown to depend on the presence of Chol [105, 106] , a phenomenon that suggests an adaptation of the antibody for recognition of gp41 sequences in the environment provided by the virion external membrane-interface. In contrast, 4E10 did not efficiently blocked perturbations induced in PC:SPM vesicles, presumably because the MPER epitope gets occluded in the transmembrane pores responsible for permeabilization of this type of vesicles [105, 106] .
This point is further illustrated by the results displayed in Figure 4 . The depth of insertion of peptides bound to membrane-surfaces can be assessed by determining their accessibility to proteolytic degradation by proteinase K [118] . Figure 4A Results shown in panels B and C demonstrate that the degree of accessibility correlates with the capacity of 4E10 for extracting the peptide from lipid monolayers and for binding to large unilamellar vesicles containing the peptide, respectively. These data also correlate the presence of Chol with the accessibility for antibody binding. Chol alters the material properties of the bilayer acting against membrane deformation [119] .
However, deformation is required for generating the vacancy in the bilayer that allows MPER insertion. So, it is likely that the higher degree of phospholipid cohesion induced
by Chol results in shallower insertion of the MPER epitope, which allows easier access to the antibody. In the ternary mixture, conditions for Lo-Ld fluid phase co-existence are produced [120] . We have recently shown that MPER peptides might be confined into the Ld phase in laterally segregated systems [107] . In this case, the local increase of the surface concentration of exposed peptide-epitope is likely to result in more efficient mAb binding by enhancing avidity.
In summary, the phenomenon of membrane-inserted epitope binding by anti-MPER antibodies constitutes a new paradigm of molecular recognition evolving in the particular milieu provided by the MI [111, 114, 115] . This bilayer region consists of a complex mixture of water and chemically heterogeneous phospholipid groups (polar head groups, glyceryl, phosphoryl, carbonyl and methylene groups) in which significant changes in polarity occur at short range [121] . Peptide sequence length, hydrophobicity distribution, membrane material properties and lipid composition are all parameters predicted to condition antibody recognition-blocking at the MI by modulating the conformation, aggregation state and bilayer topology adopted by the membrane-inserted MPER epitope. We surmise that upcoming effective MPER-directed immunogens will be built on the optimization of those parameters.
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